ZUR HAUSEN, H. Papillomavirus and cancer : from basic studies to clinical application. Nat Rev Cancer. 2002, 2, 342-350
The current status of development of prophylactic vaccines against human papillomavirus infection. Report of a technical meeting. 1999 ; Geneva, 16-18 February. 1999
KOUTSKY, LA. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 347, 1645-1651
VILLA, LL. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine. 2006, 24, 27-28, 5571-5583
VILLA, LL. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer. 2006, 95, 11, 1459-1466